-
Jiangsu Shentong and Neway Co., Ltd. were listed in the 2022 Jiangsu Top 100 Private Enterprise Innovation
Time of Update: 2023-01-04
In the first half of 2022, the revenue of Jiangsu Shentong energy industry was 300 million yuan, a year-on-year increase of 14.
-
Lianchuang Polyurethane, a subsidiary of Lianchuang Co., Ltd., plans to set up Shandong Lianchuang Plastic Technology with 100 million yuan
Time of Update: 2022-08-25
(tentative name, specific to market supervision and management The result of the approval of the department shall prevail) Lianchuang Co.
(tentative name, specific to market supervision and management The result of the approval of the department shall prevail) .
-
Jinling Petrochemical Co., Ltd. is 100% qualified for the flood season water indicators ahead of schedule
Time of Update: 2022-08-12
They improved the flood prevention plan, increased the frequency of observations of dock trestle bridges, barges, hose yards, and river surface, tracked the flow of water in the factory area, and hour duty and inspection system, and set up a rescue assault team to stand by at any time.
-
Shanghai Zhenge Biotechnology Co., Ltd. raised US$100 million in Series C financing, led by Goldman Sachs and Sofina
Time of Update: 2022-01-24
Chen Jianxin, Chairman and CEO of Zhenge Bio, said: "We are delighted to be led by top international investment institutions such as Goldman Sachs Asset Management, Sofina and Novo Holdings in this round of financing, and thank them for their recognition and support of Zhen Ge Bio.
-
Jixing Pharmaceutical Co., Ltd. over 100 million US dollars introduces tachycardia nasal administration therapy
Time of Update: 2021-07-06
On May 17, Milestone Pharmaceuticals, an innovative cardiovascular drug research and development company, announced that it has reached an exclusive license and cooperation agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil for paroxysmal rooms in Greater China.
-
Aitubang member company Runtai Co., Ltd. ranks among the top 100 Sinopec private enterprises in 2018!
Time of Update: 2021-05-01
With the purpose of innovation, Runtai Chemicals continuously develops new products and services to meet the needs of the coatings market and cope with many challenges facing the world.
-
Lomon Baili (002601.SZ) intends to acquire 100% equity of Chaoyang Dongzirconium New Material Co., Ltd.
Time of Update: 2021-04-27
(hereinafter referred to as "Eastern Zirconium"), a subsidiary of the company, at a transaction price of 164 million yuan.
After the completion of this transaction, Yunnan Guotai will own 100% of Chaoyang Dongzirconium.
-
Aitubang member company Runtai Co., Ltd. ranks among the top 100 Sinopec private enterprises in 2018!
Time of Update: 2021-03-29
With the purpose of innovation, Runtai Chemicals continuously develops new products and services to meet the needs of the coatings market and cope with many challenges facing the world.
-
Henrey and Oncolyse terminate $100 million co-development agreement
Time of Update: 2020-06-17
" Pharmaceutical Network Corporate News : June 9, Jiangsu Hengrui Pharmaceutical Co., Ltd announced that it has agreed with Japan's Oncolys Corporation to terminate the relevant cooperation related
-
Fosun Pharmaceutical: Chongqing Yaoyou plans to transfer 100% equity of GSK Pharmaceutical (Suzhou) Co., Ltd. to no more than 250 million yuan
Time of Update: 2019-07-09
On the evening of July 8, Fosun Pharmaceutical released a corporate announcement, disclosing that its holding subsidiary Chongqing Yaoyou and GlaxoSmithKline pharmaceuticals (Suzhou) Co., Ltd (hereina
-
Another biological similar medicine report of Lizhu Pharmaceutical Co., Ltd., with R & D investment of nearly 100 million
Time of Update: 2019-02-13
On December 13, Lizhu pharmaceutical announced that the registration application for the production of recombinant human chorionic gonadotropin for injection submitted by Zhuhai Lizhu monoclonal antib
-
2013 revenue of China Resources Pharmaceutical Co., Ltd. has been promoted to 100 billion yuan. There is no timetable for its overall listing
Time of Update: 2014-01-09
Source: First Financial Daily on January 9, 2014, following Sinopharm group, China Resources Pharmaceutical Group also promoted to the 100 billion club in 2013, becoming the second largest pharmaceuti